Trailing Dividend / Share
$2.51
Calidi Biotherapeutics, Inc. (CLDI) Dividend History
Income profile from 2020 to 2024 with payout safety and yield-on-cost trend
Dividend Yield
100.0%
Payout Ratio
N/A
Unknown
Dividend Streak
1 years
CLDI Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
1 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
CLDI Dividend Scorecard
Yield & Income
Dividend Yield100.0%
Trailing DPS$2.51
FrequencyN/A
Payments / 12M0
Payout Safety
Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score4/9
Growth
Growth Streak1 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown
Total Returns
Buyback Yield0.0%
Total Shareholder Yield100.0%
1Y Total Return-95.2%
5Y Total Return-100.0%
Estimated $10K growth (return + dividends):
5Y ago$110Y ago$120Y ago$1
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
CLDI Dividend History
No dividend payment history available
This company has not paid dividends during the available data period.
Get CLDI's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
Calidi Biotherapeutics, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 4/9 — moderate financial health.
Growth Track Record
CLDI has raised its dividend for 1 consecutive year.
Total Shareholder Returns
Beyond cash dividends, CLDI returns capital through share repurchases. The combined picture: 100.0% dividend yield, 100.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -100.0%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $1 today.
CLDI Annual Dividend History (2020–2024)
5 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | — | 0 | $-35.70 | — | — | — |
| 2023 | $0.00 | — | 0 | $-207.61 | — | — | — |
| 2022 | $0.00 | — | 0 | $-358.80 | — | — | — |
| 2021 | $0.00 | — | 0 | $14.16 | — | — | — |
| 2020 | $0.00 | — | 0 | $-2.64 | — | — | — |
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
6+ years return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
CLDI — Frequently Asked Questions
Quick answers to the most common questions about buying CLDI stock.
How much dividend does CLDI pay per share?
Calidi Biotherapeutics, Inc. (CLDI) pays a trailing 12-month dividend of $2.51 per share, with a current dividend yield of +100.0%. Payments are made quarterly.
When is CLDI's next ex-dividend date?
CLDI's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. CLDI typically pays dividends quarterly.
Is CLDI's dividend safe?
CLDI's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The 1-year growth streak provides moderate confidence.
How many years has CLDI increased its dividend?
CLDI has 1 consecutive years of dividend growth. The 5-year dividend CAGR is N/A.
How often does CLDI pay dividends?
Calidi Biotherapeutics, Inc. pays dividends quarterly. The trailing 12-month total is $2.51 per share. Dividend data on this page covers 4+ years from 2020 to 2024.
How much would $10,000 invested in CLDI grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in CLDI five years ago would be worth approximately $1 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is CLDI's yield on cost for long-term holders?
CLDI's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's +100.0% market yield, thanks to the lower original cost basis.